 Introduction
Definition Incidence Cause Symptoms Intestinal
Endometriosis Infertility Diagnosis Treatment Adenomyosis Are
you too young to have a
laparoscopy? Endometriosis and cancer Treatment
summary Endometriosis and heredity InfertilityPhysician.com
Home | Endometriosis and
Cancer
One question frequently asked by women with endometriosis concerns the
possible relationship between their endometriosis and the development
of some form of cancer. There has not been much data developed concerning
this issue but there has been some recent publications offering some new
information.
There are several issues that need discussion. First, is whether or not
endometriosis itself becomes malignant.
I treat as much if not more endometriosis than anyone else in the metropolitan
Philadelphia area. In over twenty-five years of practice, I have only
seen one case of endometriosis itself become malignant. Therefore, such
a transformation must be exceedingly rare.
This becomes a relevant issue when women with a history of endometriosis
either undergo a hysterectomy or go through natural menopause. In the
discussions that I have with these women, I am frequently asked whether
the estrogen therapy will stimulate the endometriosis (it might) and whether
that stimulation will cause it to become malignant (we don't know). It
is certainly well established that if a woman still has her uterus and
is given estrogen alone (without progesterone) there is a small but measurable
increase in the risk of developing uterine (endometrial) cancer.
Since endometriosis implants are in fact endometrium, it would seem reasonable
to conclude that they too are capable of undergoing the same sort of malignant
transformation as the normal endometrium inside the uterus. However, I
have never seen this happen. The one case of endometrioid cancer arising
in endometriosis that I have seen occurred in a premenopausal woman who
had not been taking any Hormone Replacement Therapy.
It must be kept in mind that the endometrium in the endometriosis implants
is not normal endometrial tissue. Studies have been done that show this
tissue does not always respond to hormones the same way the normal tissue
inside the uterus responds. This may serve as a protective mechanism.
Another issue is the fact that it has only been relatively recently that
large numbers of postmenopausal women with a history of endometriosis
have been given Hormone Replacement Therapy. It will take another five
to ten years to determine whether there is cause for concern.
The other major issue is whether women who have endometriosis are at increased
risk to develop other forms of cancer. A recent study from Sweden suggests
that women with a history of endometriosis are more likely to develop
breast cancer, thyroid cancer and non-Hodgkin's Lymphoma. These cancers
were noted to be more common in women with non-ovarian endometriosis and
adenomyosis.
An increased risk of ovarian cancer was noted in women with ovarian endometriosis.
This is the first report that I have seen suggesting an increased risk
of these cancers in women with endometriosis. The fact that this report
came from Sweden may been significant. I have seen other epidemiological
studies reported from Sweden where the statistics were faulty. Many of
these studies looked at small groups of patients and then tried to project
those numbers onto a larger population. These kinds of statistical analyses
may suggest a relationship but do not prove it definitely.
The question naturally arises - why do women with endometriosis develop
these cancers more frequently? It is less likely that having endometriosis
itself somehow predisposes women to develop these cancers. It is much
more likely that women with endometriosis develop these cancers because
they share common causes.
As I have indicated elsewhere in this pamphlet, there is now overwhelming
evidence that environmental pollution plays a major role in the development
of endometriosis. Endometriosis can be induced experimentally in monkeys
by giving them PCB's and dioxin. We know that our environment is heavily
polluted with both of these substances.
There is also very strong evidence suggesting that breast cancer is related
to PCB and dioxin. The chemical industry does not want you to know this
because they are afraid of the lawsuits that will be generated. Nonetheless,
there is good data to suggest a strong link. Since both endometriosis
and breast cancer are linked to dioxin, this may be the common denominator.
There is also evidence linking non-Hodgkin's Lymphoma to environmental
pollution as well.
It is not so easy to develop a common link between ovarian endometriosis
and ovarian cancer. If there were such a link, one would expect that endometriosis
of the ovary would lead to endometrioid cancer of the ovary but this is
a very rare form of ovarian cancer.
A more likely explanation is that endometriosis is associated with reduced
fertility. Women who have never had children are at greater risk to develop
ovarian cancer. Each baby reduces a woman's risk of ovarian cancer by
twenty percent.
It also must be mentioned here that those women who have undergone hormone
treatment for the correction of infertility are NOT at increased risk
to develop ovarian cancer. There were a few published papers several years
ago suggesting an increased risk in women who took either Clomiphene or
Pergonal (or similar drugs). A recent publication clearly showed that
there is no increased risk.
It is important that you understand that this is only preliminary data
but it is important to keep it in mind - particularly for those women
who are contemplating hysterectomy. The decision to remove or conserve
at least one ovary must be balanced against the possible increased risk
of ovarian cancer. As I have already noted, there is the unknown risk
of developing cancer in the endometriosis implants themselves although
I believe that time will prove this to be a very rare complication.
Copyright © 2008
Web Design New York
All materials on this
site are property of Michael D. Birnbaum, MD, PC
|